Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
| (Q1)Dec 31, 2025 | (FY)Sep 30, 2025 | (Q4)Sep 30, 2025 | (Q3)Jun 30, 2025 | (Q2)Mar 31, 2025 | (Q1)Dec 31, 2024 | (FY)Sep 30, 2024 | (Q4)Sep 30, 2024 | (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -11.02%-42.29K | -977.00%-37.21K | -19.58%3.64K | -1,679.21%-3.17K | 105.58%415 | -619.50%-38.1K | 112.06%4.24K | 108.56%4.52K | -100.88%-178 | 64.27%-7.43K |
| Net income from continuing operations | 26.20%-41.24K | 32.92%-224.99K | 11.12%-55.72K | 30.20%-46.15K | 31.71%-67.25K | 48.33%-55.88K | 49.42%-335.41K | 36.52%-62.69K | 21.37%-66.11K | 77.17%-98.47K |
| Asset impairment expenditure | ---- | 13.17%3.95K | ---- | ---- | ---- | ---- | -93.80%3.49K | ---- | ---- | ---- |
| Remuneration paid in stock | --0 | -98.09%1.77K | --0 | --0 | -99.37%247 | -96.58%1.52K | -70.65%92.61K | 107.48%3.35K | --5.73K | -89.15%39.09K |
| Change In working capital | -106.48%-1.05K | -25.25%182.05K | -8.23%55.4K | -28.61%42.98K | 29.75%67.41K | -77.11%16.26K | -4.89%243.55K | 75.55%60.37K | -42.30%60.2K | 3.50%51.96K |
| -Change in receivables | 4.74%-2.07K | 127.25%645 | -29.46%-2.34K | 422.81%8.54K | -16.48%-3.38K | -143.60%-2.17K | -115.97%-2.37K | 14.65%-1.81K | -211.94%-2.64K | 8.83%-2.9K |
| -Change in payables and accrued expense | -94.49%1.02K | -26.23%181.41K | -7.13%57.74K | -45.19%34.45K | 29.05%70.79K | -72.09%18.43K | 1.94%245.92K | 70.32%62.18K | -38.37%62.85K | 2.77%54.86K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -11.02%-42.29K | -977.00%-37.21K | -19.58%3.64K | -1,679.21%-3.17K | 105.58%415 | -619.50%-38.1K | 112.06%4.24K | 108.56%4.52K | -100.88%-178 | 64.27%-7.43K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -1.79K | 0.78%-3.92K | 0 | 83.17%-3.95K | -13.17%-3.95K | |||||
| Net PPE purchase and sale | ---1.79K | 0.78%-3.92K | ---- | ---- | ---- | --0 | 83.17%-3.95K | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---1.79K | 0.78%-3.92K | ---- | ---- | ---- | --0 | 83.17%-3.95K | -13.17%-3.95K | ---- | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 80.70%72.1K | 39.9K | 0 | 0 | 0 | 39.9K | 0 | 0 | 0 | 0 |
| Proceeds from stock option exercised by employees | --0 | --39.9K | --0 | --0 | --0 | --39.9K | --0 | --0 | --0 | --0 |
| Net other financing activities | --72.1K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 80.70%72.1K | --39.9K | --0 | --0 | --0 | --39.9K | --0 | --0 | --0 | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -69.39%544 | 19.50%1.78K | -31.35%830 | 188.18%4K | -59.39%3.58K | 19.50%1.78K | -96.30%1.49K | -96.80%1.21K | -96.31%1.39K | -84.89%8.82K |
| Current changes in cash | 1,452.35%28.02K | -525.17%-1.23K | -150.35%-286 | -1,679.21%-3.17K | 105.58%415 | -75.39%1.81K | 100.75%290 | 101.56%568 | -171.49%-178 | 64.27%-7.43K |
| End cash Position | 697.43%28.56K | -69.39%544 | -69.39%544 | -31.35%830 | 188.18%4K | -59.39%3.58K | 19.50%1.78K | 19.50%1.78K | -96.80%1.21K | -96.31%1.39K |
| Free cash from | -15.71%-44.08K | -14,283.79%-41.13K | -150.35%-286 | -1,679.21%-3.17K | 105.58%415 | -619.50%-38.1K | 100.49%290 | 100.74%568 | -100.88%-178 | 64.27%-7.43K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.